Macrophages can alternate between two states: an inflammatory state for fighting infection and a non-inflammatory state for ...

Silent Crohn’s disease' is a form of inflammatory bowel disease that may develop without typical or obvious symptoms.

Crohn’s Disease can affect any part of the gastrointestinal tract, but most commonly targets the terminal ileum and proximal colon. A key characteristic of Crohn’s is transmural involvement, meaning ...

Under the current therapeutic paradigm, low-risk disease progression is defined as patients with mild presentation, inflammatory disease, absence of perianal disease or extraintestinal manifestations ...

Common unpleasant symptoms after eating too much of the wrong thing happen to just about anyone. Cramping, nausea, abdominal pain or gas typically don’t last long, but if you have Crohn’s disease, ...

Bhat: I love this question! Crohn’s disease treatment has progressed significantly in recent years, incorporating new mechanisms of action such as interleukin inhibitors and Janus kinase inhibitors.

If you recently learned that you have Crohn’s disease, you’re not alone. According to the National Institutes of Health, roughly 1 million people in the United States are living with this digestive ...

If you live with Crohn’s disease, you’re already familiar with the incessant fatigue, abdominal pain, and diarrhea that comes along with a Crohn’s diagnosis. Crohn’s is an autoimmune disorder that ...

Crohn's disease is a chronic inflammatory bowel disease (IBD) that affects the digestive tract, often causing abdominal pain, persistent diarrhea, rectal bleeding, weight loss, and fatigue during ...

The FDA recently designated Yuflyma as "interchangeable" with the popular biologic Humira for the treatment of Crohn's disease and ulcerative colitis, two types of inflammatory bowel disease (IBD), ...

Expert Rev Gastroenterol Hepatol. 2010;4(2):167-180. Expert Rev Gastroenterol Hepatol. 2010;4(2):167-180. © 2010 Expert Reviews Ltd. Cite this: What is the Optimal ...